CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) today announced that it has expanded its Board of Directors with the addition of four industry leaders in healthcare. The new, independent directors joining the Board include healthcare Industry veterans: David R. Epstein, President and CEO of Novartis Oncology; Dr. Yvonne Greenstreet, Senior Vice President and Chief of Strategy, R&D, GlaxoSmithKline; Joseph M. Limber, President and Chief Executive Officer of Prometheus Laboratories, Inc.; and Dr. Anthony F. Martin, Founder and Managing Partner of TMA Consultants.
